These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39412060)

  • 1. Alpha 1 antitrypsin augmentation for alpha 1 antitrypsin deficiency associated lung disease.
    Glaister P; Hindle Robinson N; Ward A; Bentham C; Crossingham I
    Cochrane Database Syst Rev; 2024 Oct; 10(10):CD015930. PubMed ID: 39412060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Sandhaus RA
    COPD; 2009 Jun; 6(3):147-8. PubMed ID: 19811367
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease.
    Gøtzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007851. PubMed ID: 20614465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation therapy for alpha-1 antitrypsin deficiency--not enough evidence to support its use yet!
    McCarthy C; Dimitrov BD
    COPD; 2010 Jun; 7(3):234; author reply 235-6. PubMed ID: 20486824
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lack of effect of substitution therapy of alpha1-antitrypsin deficiency].
    Dahl R; Hilberg O; Løkke A; Pedersen L; Ringbæk T; Titlestad I
    Ugeskr Laeger; 2011 Oct; 173(42):2645-7. PubMed ID: 22027165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
    Campos MA; Lascano J
    Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha1-antitrypsin deficiency: forgotten etiology.
    Kaplan A; Cosentino L
    Can Fam Physician; 2010 Jan; 56(1):19-24. PubMed ID: 20090075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous alpha-1 antitrypsin augmentation therapy: systematic review.
    Gøtzsche PC; Johansen HK
    Dan Med Bull; 2010 Sep; 57(9):A4175. PubMed ID: 20816015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis.
    Chapman KR; Stockley RA; Dawkins C; Wilkes MM; Navickis RJ
    COPD; 2009 Jun; 6(3):177-84. PubMed ID: 19811373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of augmentation therapy in alpha-1 antitrypsin deficiency.
    Kueppers F
    Curr Med Res Opin; 2011 Mar; 27(3):579-88. PubMed ID: 21226542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
    Barjaktarevic I; Miravitlles M
    BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of Abrupt Cessation of Alpha
    McElvaney OJ; Carroll TP; Franciosi AN; Sweeney J; Hobbs BD; Kowlessar V; Gunaratnam C; Reeves EP; McElvaney NG
    N Engl J Med; 2020 Apr; 382(15):1478-1480. PubMed ID: 32268034
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.
    Dummer J; Dobler CC; Holmes M; Chambers D; Yang IA; Parkin L; Smith S; Wark P; Dev A; Hodge S; Dabscheck E; Gooi J; Samuel S; Knowles S; Holland AE
    Respirology; 2020 Mar; 25(3):321-335. PubMed ID: 32030868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice. Alpha1-antitrypsin deficiency.
    Silverman EK; Sandhaus RA
    N Engl J Med; 2009 Jun; 360(26):2749-57. PubMed ID: 19553648
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis.
    Campos MA; Runken MC; Davis AM; Johnson MP; Stone GA; Buikema AR
    Adv Ther; 2018 Apr; 35(4):467-481. PubMed ID: 29616482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha1-antitrypsin deficiency.
    Gøtzsche PC; Johansen HK
    N Engl J Med; 2009 Nov; 361(21):2101-2; author reply 2102. PubMed ID: 19923584
    [No Abstract]   [Full Text] [Related]  

  • 20. Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies.
    Turner AM
    BioDrugs; 2013 Dec; 27(6):547-58. PubMed ID: 23771682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.